NanoViricides
NNVC
#10560
Rank
C$50.7 M
Marketcap
C$1.99
Share price
1.43%
Change (1 day)
-1.95%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: C$50.7 Million

As of September 2026 NanoViricides has a market cap of C$50.7 Million. This makes NanoViricides the world's 10560th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026C$50.7 M44.24%
2025C$35.14 M13.82%
2024C$30.88 M94.33%
2023C$15.89 M-9.13%
2022C$17.48 M-68%
2021C$54.63 M40%
2020C$39.02 M207.58%
2019C$12.68 M-32.99%
2018C$18.93 M-72.98%
2017C$70.08 M-16.26%
2016C$83.69 M-11.58%
2015C$94.64 M-46.99%
2014C$0.17 B-30.17%
2013C$0.25 B243.65%
2012C$74.4 M-19.71%
2011C$92.66 M-54.56%
2010C$0.20 B72.87%
2009C$0.11 B-2.38%
2008C$0.12 B160.69%
2007C$46.35 M

End of Day market cap according to different sources

On Sep 19th, 2026 the market cap of NanoViricides was reported to be:

C$50.7 Million
by Nasdaq info icon info icon
C$50.7 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
C$260.33 B 513,377.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$506.82 B 999,527.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$180.17 B 355,259.20%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$140.68 B 277,373.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
C$2.33 B 4,500.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$3.10 B 6,018.94%๐Ÿ‡บ๐Ÿ‡ธ USA